Literature DB >> 14978076

Human thymus exports naive CD8 T cells that can home to nonlymphoid tissues.

Alfred Zippelius1, Gilles Bioley, Frédérique-Anne Le Gal, Nathalie Rufer, Marlene Brandes, Pascal Batard, Magda De Smedt, Jean Plum, Daniel E Speiser, Jean-Charles Cerottini, Pierre-Yves Dietrich, Pedro Romero, Mikaël J Pittet.   

Abstract

Functionally naive CD8 T cells in peripheral blood from adult humans can be fully described by their CD45RA(bright)CCR7(+)CD62L(+) cell surface phenotype. Cord blood lymphocytes, from healthy newborns, are homogenously functionally naive. Accordingly, the majority of cord blood CD8 T cells express the same pattern of cell surface molecules. Unexpectedly, however, a significant fraction of cord blood CD8 T cells express neither CCR7 nor CD62L. Yet these cells remain functionally naive as they contain high levels of TCR excision circles, have long telomeres, display highly polyclonal TCRs, and do not exhibit immediate effector functions. In addition, these CD8 T cells already represent a significant fraction of the mature naive CD8 single-positive thymocyte repertoire and may selectively express the cutaneous lymphocyte Ag. We suggest that CD8 single-positive thymocytes comprise two pools of naive precursors that exhibit distinct homing properties. Once seeded in the periphery, naive CCR7(+)CD62L(+) CD8 T cells patrol secondary lymphoid organs, whereas naive CCR7(-)CD62L(-) CD8 T cells selectively migrate to peripheral tissues such as skin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978076     DOI: 10.4049/jimmunol.172.5.2773

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Re-entry of mature T cells to the thymus: an epiphenomenon?

Authors:  Jonathan Sprent; Charles D Surh
Journal:  Immunol Cell Biol       Date:  2008-12-02       Impact factor: 5.126

Review 2.  Human intrathymic development: a selective approach.

Authors:  J Plum; M De Smedt; G Leclercq; T Taghon; T Kerre; B Vandekerckhove
Journal:  Semin Immunopathol       Date:  2008-10-17       Impact factor: 9.623

3.  Tumor masses support naive T cell infiltration, activation, and differentiation into effectors.

Authors:  Elizabeth D Thompson; Hilda L Enriquez; Yang-Xin Fu; Victor H Engelhard
Journal:  J Exp Med       Date:  2010-07-26       Impact factor: 14.307

4.  Identification of a novel human memory T-cell population with the characteristics of stem-like chemo-resistance.

Authors:  Kenji Murata; Tomohide Tsukahara; Makoto Emori; Yuji Shibayama; Emi Mizushima; Hiroshi Matsumiya; Keiji Yamashita; Mitsunori Kaya; Yoshihiko Hirohashi; Takayuki Kanaseki; Terufumi Kubo; Tetsuo Himi; Shingo Ichimiya; Toshihiko Yamashita; Noriyuki Sato; Toshihiko Torigoe
Journal:  Oncoimmunology       Date:  2016-06-08       Impact factor: 8.110

5.  Extranodal induction of therapeutic immunity in the tumor microenvironment after intratumoral delivery of Tbet gene-modified dendritic cells.

Authors:  L Chen; J L Taylor; N C Sabins; D B Lowe; Y Qu; Z You; W J Storkus
Journal:  Cancer Gene Ther       Date:  2013-07-12       Impact factor: 5.987

6.  Decreased absolute numbers of CD3+ T cells and CD8+ T cells during aging in herpes zoster patients.

Authors:  Li Wei; Jianguang Zhao; Wei Wu; Yu Zhang; Xuyan Fu; Lifeng Chen; Xiaoting Wang
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

7.  Association Between Programed Cell Death-1 and CD4+ T Cell Alterations in Different Phases of Ischemic Stroke Patients.

Authors:  Yi Zhang; Li Wei; Yupeng Du; Yirui Xie; Wei Wu; Yuan Yuan
Journal:  Front Cell Neurosci       Date:  2018-06-22       Impact factor: 5.505

8.  The molecular and phenotypic makeup of fetal human skin T lymphocytes.

Authors:  René Reitermaier; Tanya Ayub; Julia Staller; Philip Kienzl; Nikolaus Fortelny; Pablo Augusto Vieyra-Garcia; Christof Worda; Christian Fiala; Clement Staud; Wolfgang Eppel; Anke Scharrer; Thomas Krausgruber; Adelheid Elbe-Bürger
Journal:  Development       Date:  2021-10-26       Impact factor: 6.868

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.